Result: Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity

*Title*:

Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity : the CERTAIN double-blind, randomised, placebo-controlled trial / J. S. Smolen ; P. Emery ; G. F. Ferraccioli ; W. Samborski ; F. Berenbaum ; O. R. Davies ; W. Koetse ; O. Purcaru ; B. Bennett ; H. Burkhardt

*Author/editor-in-chief*:

*Published in*:

Annals of the rheumatic diseases. - [Amsterdam] : Elsevier, 1939-. - ISSN 1468-2060. - Band 2014, Heft 0 (2014)
*show_all_articles*

*Manufacture*:

2014

*Physical description scale*:

Online-Ressource

*Format*:

*eArticle*

*Language*:

*eng*

*DOI*:

10.1136/annrheumdis-2013-204632

*Result*: Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity